Cargando…

Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation

BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women age...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminawung, Jenerius A., Hoag, Jessica R., Kyanko, Kelly A., Xu, Xiao, Richman, Ilana B., Busch, Susan H., Gross, Cary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402830/
https://www.ncbi.nlm.nih.gov/pubmed/32537899
http://dx.doi.org/10.1002/cam4.3218
_version_ 1783566833129881600
author Aminawung, Jenerius A.
Hoag, Jessica R.
Kyanko, Kelly A.
Xu, Xiao
Richman, Ilana B.
Busch, Susan H.
Gross, Cary P.
author_facet Aminawung, Jenerius A.
Hoag, Jessica R.
Kyanko, Kelly A.
Xu, Xiao
Richman, Ilana B.
Busch, Susan H.
Gross, Cary P.
author_sort Aminawung, Jenerius A.
collection PubMed
description BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women aged 40‐59 years who received a routine screening mammogram in the past 18 months. Survey items included the following topics regarding supplemental screening: discussing risks or benefits with a provider, knowledge about the risk of false positives, and utilization. We grouped women by state DBN into non‐DBN, generic DBN (mentions breast density but not supplemental screening), DBN that mentions supplemental screening (DBN‐SS), and DBN with mandated insurance coverage for supplemental screening (DBN‐coverage), and estimated adjusted predicted probabilities for supplemental screening behaviors. RESULTS: Of 1641 women surveyed, 21.3% resided in non‐DBN, 41.2% in generic DBN, 25.8% in DBN‐SS, and 12.5% in DBN‐coverage states. Overall, 23.0% of respondents had discussed supplemental screening with a provider, 11.3% of whom discussed the risks, and 49.5% discussed the benefits. In adjusted analysis, women living in DBN‐coverage states were more likely to discuss supplemental screening (27.5%) than women in non‐DBN states (13.6%); pairwise contrast 13.8% (95% CI, 2.1% to 25.6%; P = .01). They were also more likely to have received supplemental screening for increased breast density (19.3%) compared to women living in non‐DBN (9.9%); contrast 9.4% (95% CI, 1.6% to 17.3%; P = .01), Generic DBN (7.3%); difference 12.0% (95% CI, 4.6% to 19.4%; P =< .001), and DBN‐SS (8.8%); contrast 10.5% (95% CI, 2.6% to 18.5%; P < .01) states. CONCLUSIONS: Women in DBN‐coverage states were more likely to discuss supplemental screening with their providers, and to undergo supplemental screening, compared to women in states with other types of DBN laws, or without DBN laws.
format Online
Article
Text
id pubmed-7402830
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74028302020-08-06 Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation Aminawung, Jenerius A. Hoag, Jessica R. Kyanko, Kelly A. Xu, Xiao Richman, Ilana B. Busch, Susan H. Gross, Cary P. Cancer Med Cancer Prevention BACKGROUND: Given the growth in dense breast notification (DBN) legislation in the United States, we examined the association between different types of DBN laws and supplemental screening behaviors among women. METHODS: We surveyed in March–April 2018 a nationally representative sample of women aged 40‐59 years who received a routine screening mammogram in the past 18 months. Survey items included the following topics regarding supplemental screening: discussing risks or benefits with a provider, knowledge about the risk of false positives, and utilization. We grouped women by state DBN into non‐DBN, generic DBN (mentions breast density but not supplemental screening), DBN that mentions supplemental screening (DBN‐SS), and DBN with mandated insurance coverage for supplemental screening (DBN‐coverage), and estimated adjusted predicted probabilities for supplemental screening behaviors. RESULTS: Of 1641 women surveyed, 21.3% resided in non‐DBN, 41.2% in generic DBN, 25.8% in DBN‐SS, and 12.5% in DBN‐coverage states. Overall, 23.0% of respondents had discussed supplemental screening with a provider, 11.3% of whom discussed the risks, and 49.5% discussed the benefits. In adjusted analysis, women living in DBN‐coverage states were more likely to discuss supplemental screening (27.5%) than women in non‐DBN states (13.6%); pairwise contrast 13.8% (95% CI, 2.1% to 25.6%; P = .01). They were also more likely to have received supplemental screening for increased breast density (19.3%) compared to women living in non‐DBN (9.9%); contrast 9.4% (95% CI, 1.6% to 17.3%; P = .01), Generic DBN (7.3%); difference 12.0% (95% CI, 4.6% to 19.4%; P =< .001), and DBN‐SS (8.8%); contrast 10.5% (95% CI, 2.6% to 18.5%; P < .01) states. CONCLUSIONS: Women in DBN‐coverage states were more likely to discuss supplemental screening with their providers, and to undergo supplemental screening, compared to women in states with other types of DBN laws, or without DBN laws. John Wiley and Sons Inc. 2020-06-14 /pmc/articles/PMC7402830/ /pubmed/32537899 http://dx.doi.org/10.1002/cam4.3218 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Aminawung, Jenerius A.
Hoag, Jessica R.
Kyanko, Kelly A.
Xu, Xiao
Richman, Ilana B.
Busch, Susan H.
Gross, Cary P.
Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title_full Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title_fullStr Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title_full_unstemmed Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title_short Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
title_sort breast cancer supplemental screening: women’s knowledge and utilization in the era of dense breast legislation
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402830/
https://www.ncbi.nlm.nih.gov/pubmed/32537899
http://dx.doi.org/10.1002/cam4.3218
work_keys_str_mv AT aminawungjeneriusa breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT hoagjessicar breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT kyankokellya breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT xuxiao breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT richmanilanab breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT buschsusanh breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation
AT grosscaryp breastcancersupplementalscreeningwomensknowledgeandutilizationintheeraofdensebreastlegislation